Merck
Index128569. Gerlachet al (1992) The molecular
pharmacology of L-deprenyl. Eur.J.Pharmacol.Mol.Pharmacol.Sect. 226
97. Kotakeet al (1998) Deprenyl decreases an endogenous
parkinsonism-inducing compound, 1-benzyl-1,2,3,4-tetrahydroisoquinoline in
mice: in vivo and in vitro studies. Brain Res. 787 341. Mercuriet al (1998) Modification of levodopa responses by deprenyl
(selegiline): an electrophysiological and behavioural study in the rat relevant
to Parkinson's disease. Ann.Neurol. 43 613. Kasedaet
al (1999) Effect of selegeline on dopamine concentration in the striatum of
a primate. Brain Res. 815 44.